跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Modulin
首页
药物
Modulin
Modulin
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
USE OF PHENOL-SOLUBLE MODULINS FOR VACCINE DEVELOPMENT
US 2011268757 A1
申请人: PASTEUR INSTITUT
优先权: 2008
CN
EP
US
3 件公开
MOLECULAR BACTERIOTHERAPY TO CONTROL SKIN ENZYMATIC ACTIVITY
WO 2019046801 A1
申请人: UNIV CALIFORNIA
优先权: 2017
CN
WO
2 件公开
Toxoid peptides derived from phenol soluble modulin, delta toxin, superantigens, and fusions thereof
US 9815872 B2
申请人: INTEGRATED BIOTHERAPEUTICS INC
优先权: 2014
US
2 件公开
ANTIMICROBIAL AND ANTI-INFLAMMATORY THERAPIES AND COMPOSITIONS
US 2010166708 A1
申请人: UNIV CALIFORNIA
优先权: 2008
US
Antimicrobial peptides and uses thereof
US 10717766 B2
申请人: TECHNION RES & DEV FOUNDATION
优先权: 2017
US
Protein-based sensors for metals in environmental samples and uses thereof
CN 117881694 A
申请人: PENN STATE RES FOUND
优先权: 2021
CN
Recombinant urine modulin fragment product and application thereof in inhibition of complement activation
CN 116948000 A
申请人: UNIV PEKING FIRST HOSPITAL
优先权: 2022
CN
Lanthanum modulin homologues with improved rare earth separation properties
CN 120603840 A
申请人: PENN STATE RES FOUND
优先权: 2022
CN
Recombinant urine modulatory protein fragment with function of inhibiting epidermal growth factor receptor and application of recombinant urine modulatory protein fragment
CN 119552259 A
申请人: UNIV PEKING FIRST HOSPITAL
优先权: 2023
CN
药物
反馈